Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Catherine Bollard"'
Autor:
Nirali Shah, Lili Yang, Kasia Bourcier, Antoni Ribas, Pawel Kalinski, Ke Liu, Phil Greenberg, Carl June, Marcela Maus, Steven Rosenberg, Madhav Dhodapkar, Irina Tiper, Chantale Bernatchez, Michael Hudecek, Stanley Riddell, Stephen Gottschalk, Crystal Mackall, Lisa Butterfield, Greg Delgoffe, Michael Nishimura, Terry Fry, Marc S. Ernstoff, Christopher Klebanoff, Elad Sharon, Malcolm Brenner, Cliona Rooney, Christine Brown, Marc S Ernstoff, Tonya Webb, Magdalena Thurin, Wendell Lim, David Stroncek, Catherine Bollard, Helen Chen, Cameron Turtle, Christian Hinrichs, Laura K Fogli, Rosemarie Aurigemma, Connie L Sommers, Steven Albelda, Renier Brentjens, Yvonne Chen, Laronna Colbert, Kenneth Cornetta, Jason Cristofaro, Thomas Finn, Laura K Fogli Hunter, Alyssa Galaro, Ananda Goldrath, Ray Harris, Lori Henderson, Yuxia Jia, Dan Kaufman, Bruce Levine, Lawrence Lum, Samantha Maragh, Alex Marson, Raj Puri, Jake Reder, Isabelle Riviere, Kole Roybal, Rachelle Salomon, Tal Salz, Barbra Sasu, Andrea Schietinger, Connie L. Sommers, Minkyung Song, Fyodor Urnov, Anthony Welch, Travis Young, Jason Yovandich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Cell-based immunotherapies have had remarkable success in the clinic, specifically in the treatment of hematologic malignancies. However, these strategies have had limited efficacy in patients with solid tumors. To better understand the challenges in
Externí odkaz:
https://doaj.org/article/f4500c9773db47d7abfb74eccac2d857
Autor:
Emily Reynolds, Catherine Bollard, Amy Hont, Conrad Cruz, Maja Stanojevic, Robert Ulrey, Madeline Terpilowski, Fahmida Hoq, Maria Fortiz, Haili Lang, Jeffrey Dome, Patrick Hanley, Holly Meany
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/45fdbbf05d7e4f91b23afcbf5c345df4
Autor:
Nathan H. Fowler, Chan Yoon Cheah, Randy D. Gascoyne, John Gribben, Sattva S. Neelapu, Paolo Ghia, Catherine Bollard, Stephen Ansell, Michael Curran, Wyndham H. Wilson, Susan O’Brien, Cliona Grant, Richard Little, Thorsten Zenz, Loretta J. Nastoupil, Kieron Dunleavy
Publikováno v:
Haematologica, Vol 101, Iss 5 (2016)
The tumor microenvironment is the cellular and molecular environment in which the tumor exists and with which it continuously interacts. In B-cell lymphomas, this microenvironment is intriguing in that it plays critical roles in the regulation of tum
Externí odkaz:
https://doaj.org/article/2868e0f35ec04b72832dc6a61586daae
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1, Iss 2, Pp e2009010-e2009010 (2009)
Latent EBV infection is associated with several malignancies, including EBV post-transplant lymphoproliferative disorders (LPD), Hodgkin and non-Hodgkin lymphomas, nasopharyngeal carcinoma and Burkitt lymphoma. The range of expression of latent EBV a
Externí odkaz:
https://doaj.org/article/ff62cc5c4e894f3993af79b1fbcc2478
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1, Iss 2, Pp e2009010-e2009010 (2009)
Latent EBV infection is associated with several malignancies, including EBV post-transplant lymphoproliferative disorders (LPD), Hodgkin and non-Hodgkin lymphomas, nasopharyngeal carcinoma and Burkitt lymphoma. The range of expression of latent EBV a
Externí odkaz:
https://doaj.org/article/1487da6e2a494dcba3c4b55fca219b4e
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Nethaji Muniraj, Kajal Chaudhry, Joshua Luke Terao, Vipin Suri, Luke Barron, Catherine Bollard, Conrad Russell Cruz
Publikováno v:
Cancer Research. 83:3191-3191
Introduction: Glioblastoma (GBM) presents with a poor prognosis and dismal survival rates. While cell-based immune therapies have shown success in other malignancies, there is currently little evidence that GBM is as responsive to current approaches.
Autor:
Adora Lin, Naseem Maghzian, Shivani Chinnappan, Stephanie Norman, Christine Peng, Helen Kim, Pamela Guerrerio, Catherine Bollard
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB220
Autor:
Eugene Hwang, Fernanda Fortiz, Russell Cruz, Ashley Geiger, Melanie Grant, Haili Lang, Abeer Shibli, Sianna Burnett, Chris Lazarski, Jay Tanna, Chase McCann, Fahmida Hoq, Patrick Hanley, Lindsay Kilburn, Brian Rood, Roger Packer, Catherine Bollard
Publikováno v:
Neuro-Oncology. 24:i85-i86
BACKGROUND: The ReMIND trial hypothesizes that autologous T-cells specific for three tumor-associated antigens (TAA) -WT1, PRAME, and survivin- will be safe and elicit anti-tumor immunity in pediatric patients with CNS cancer. METHODS: Patients (n=25
Autor:
Melanie Grant, Maria Fortiz, Lu Wang, Haili Lang, Anushree Datar, Emily Reynolds, Madeleine Terpilowski, Ashley Geiger, Chris Lazarski, Jay Tanna, Adriana Pitino, Nan Zhang, Fahmida Hoq, Patrick Hanley, C Russell Cruz, Lindsay Kilburn, Roger Packer, Brian Rood, Catherine Bollard
Publikováno v:
Neuro-Oncology
Background Patients with relapsed CNS malignancies or DIPG face terrible prognoses. We hypothesized that T cells specific for 3 tumor-associated antigens (TAA), WT1, PRAME and survivin, would be safe and elicit anti-tumor immunity. Methods Patients (